furosemide has been researched along with Familial Hyperpotassemia and Hypertension in 5 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"The conditions were consistent with Type II pseudohypoaldosteronism (PHA)." | 5.30 | Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II. ( Corapçioğlu, D; Erdoğan, G; Erdoğan, MF; Hallioğlu, J; Uysal, AR, 1997) |
" The dosage of cation exchange resins was decreased, oral fluids were tolerated, and the patient's general condition improved." | 5.29 | Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia. ( Rosa, FC; Stone, RC; Vale, P, 1996) |
"The conditions were consistent with Type II pseudohypoaldosteronism (PHA)." | 1.30 | Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II. ( Corapçioğlu, D; Erdoğan, G; Erdoğan, MF; Hallioğlu, J; Uysal, AR, 1997) |
" The dosage of cation exchange resins was decreased, oral fluids were tolerated, and the patient's general condition improved." | 1.29 | Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia. ( Rosa, FC; Stone, RC; Vale, P, 1996) |
"In adults, persistent hyperkalemic distal renal tubular acidosis in the absence of impaired renal function is an unusual abnormality usually associated with the syndromes of aldosterone deficiency or resistance." | 1.29 | Pseudohypoaldosteronism with normal blood pressure. ( Laxdal, V; Morris, G; Shoker, A; Skomro, R, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castañeda-Bueno, M | 1 |
Arroyo, JP | 1 |
Zhang, J | 1 |
Puthumana, J | 1 |
Yarborough, O | 1 |
Shibata, S | 1 |
Rojas-Vega, L | 1 |
Gamba, G | 1 |
Rinehart, J | 1 |
Lifton, RP | 1 |
Stone, RC | 1 |
Vale, P | 1 |
Rosa, FC | 1 |
Shoker, A | 1 |
Morris, G | 1 |
Skomro, R | 1 |
Laxdal, V | 1 |
Kuhnle, U | 1 |
Hinkel, GK | 1 |
Hubl, W | 1 |
Reichelt, T | 1 |
Erdoğan, G | 1 |
Corapçioğlu, D | 1 |
Erdoğan, MF | 1 |
Hallioğlu, J | 1 |
Uysal, AR | 1 |
5 other studies available for furosemide and Familial Hyperpotassemia and Hypertension
Article | Year |
---|---|
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
Topics: Angiotensin II; Animals; Blood Volume; Chlorocebus aethiops; COS Cells; Cyclic AMP-Dependent Protein | 2017 |
Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium; Diuretics; Female; Furosemide; Humans; Hydrochloro | 1996 |
Pseudohypoaldosteronism with normal blood pressure.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Bicarbonates; Blood Pressure; Chlorides; Diuretics; Fem | 1996 |
Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
Topics: Adolescent; Adult; Aldosterone; Case-Control Studies; Child; Child, Preschool; Female; Furosemide; G | 1996 |
Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
Topics: Adult; Deamino Arginine Vasopressin; Diuretics; Follow-Up Studies; Furosemide; Humans; Male; Pseudoh | 1997 |